These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1690313)

  • 61. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera.
    Heidenreich F; Vincent A; Roberts A; Newsom-Davis J
    Autoimmunity; 1988; 1(4):285-97. PubMed ID: 2485125
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myasthenia gravis: T and B cell reactivities to the beta-bungarotoxin binding protein presynaptic membrane receptor.
    Link H; Sun JB; Lu CZ; Xiao BG; Fredrikson S; Höjeberg B; Olsson T
    J Neurol Sci; 1992 Jun; 109(2):173-81. PubMed ID: 1634899
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cloning and expression in Escherichia coli of a synthetic gene encoding the extracellular domain of the human muscle acetylcholine receptor alpha-subunit.
    Talib S; Leiby KR; Wright K; Okarma TB
    Gene; 1991 Feb; 98(2):289-93. PubMed ID: 2016069
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding.
    Psaridi-Linardaki L; Mamalaki A; Remoundos M; Tzartos SJ
    J Biol Chem; 2002 Jul; 277(30):26980-6. PubMed ID: 12015305
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Search for nicotinic acetylcholine receptors on human leukocytes: absence of alpha-bungarotoxin binding in studies of healthy individuals and myasthenia gravis patients.
    Kaufman RL; Oger J
    J Neuroimmunol; 1989 Jun; 23(1):83-7. PubMed ID: 2723042
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis.
    Coppedè F; Ricciardi R; Denaro M; De Rosa A; Provenzano C; Bartoccioni E; Baggiani A; Lucchi M; Mussi A; Migliore L
    PLoS One; 2013; 8(11):e80846. PubMed ID: 24260492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity.
    Vernet-der Garabedian B; Eymard B; Bach JF; Morel E
    J Neuroimmunol; 1989 Jan; 21(1):41-7. PubMed ID: 2908881
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization.
    Iacomino N; Scandiffio L; Conforti F; Salvi E; Tarasco MC; Bortone F; Marcuzzo S; Simoncini O; Andreetta F; Pistillo D; Voulaz E; Alloisio M; Antozzi C; Mantegazza R; De Pas TM; Cavalcante P
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979710
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarily in vivo binding.
    Sano M; Lambert EH; McCormick DJ; Lennon VA
    Neurology; 1992 Jan; 42(1):218-22. PubMed ID: 1734307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
    Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
    Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.
    Ching KH; Burbelo PD; Kimball RM; Clawson LL; Corse AM; Iadarola MJ
    Neuromuscul Disord; 2011 Mar; 21(3):204-13. PubMed ID: 21195619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autoantibody of NRIP, a novel AChR-interacting protein, plays a detrimental role in myasthenia gravis.
    Tsai LK; Chen IH; Chao CC; Hsueh HW; Chen HH; Huang YH; Weng RW; Lai TY; Tsai YC; Tsao YP; Chen SL
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):665-676. PubMed ID: 33773096
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunological and pharmacological heterogeneity of alpha-bungarotoxin binding sites extracted from TE671 cells.
    Walker R; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1988 Aug; 19(1-2):149-57. PubMed ID: 3397405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports.
    Fukuhara M; Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Muto S; Hasegawa T; Suzuki H
    J Thorac Dis; 2017 Jun; 9(6):1592-1597. PubMed ID: 28740673
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Unexpected cross-reactivity between myosin and a main immunogenic region (MIR) of the acetylcholine receptor by antisera obtained from myasthenia gravis patients.
    Mohan S; Barohn RJ; Krolick KA
    Clin Immunol Immunopathol; 1992 Sep; 64(3):218-26. PubMed ID: 1643755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis.
    Li Z; Forester N; Vincent A
    J Neuroimmunol; 1996 Feb; 64(2):179-83. PubMed ID: 8632060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thymomas express epitopes shared by the ryanodine receptor.
    Mygland A; Kuwajima G; Mikoshiba K; Tysnes OB; Aarli JA; Gilhus NE
    J Neuroimmunol; 1995 Oct; 62(1):79-83. PubMed ID: 7499495
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis.
    Stefansson K; Dieperink ME; Richman DP; Gomez CM; Marton LS
    N Engl J Med; 1985 Jan; 312(4):221-5. PubMed ID: 2578213
    [No Abstract]   [Full Text] [Related]  

  • 79. Characterization of a 58- and a 78-kD monocytic membrane protein with affinity to the acetylcholine receptor in myasthenia gravis patients.
    Stuhlmüller B; Kalies I; Kachelries H; Druschky KF; Kalden JR
    Scand J Immunol; 1994 Mar; 39(3):305-13. PubMed ID: 7510415
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunoperoxidase localization of alpha bungarotoxin: a new approach to myasthenia gravis.
    Bender AN; Ringel SP; Engel WK; Vogel Z; Daniels MP
    Ann N Y Acad Sci; 1976; 274():20-30. PubMed ID: 60894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.